TRAIL can bind two apoptosis-inducing receptors TRAIL-R1 (DR4) and TRAIL-R2 (DR5) [46], whereas FasL binds to CD95/Fas receptor expressed by the majority of cancer cells in PIN-SC tumors. The gene discussed is TNFRSF10B; the disease is prostate intraepithelial neoplasia.